# Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer

> **NCT00096070** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 50 (actual)

## Conditions studied

- Adenocarcinoma of the Pancreas
- Stage II Pancreatic Cancer
- Stage III Pancreatic Cancer

## Interventions

- **RADIATION:** radiation therapy
- **DRUG:** oxaliplatin
- **DRUG:** fluorouracil
- **DRUG:** gemcitabine hydrochloride

## Key facts

- **NCT ID:** NCT00096070
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2007-04
- **Final completion:** —
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2013-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00096070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00096070, "Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00096070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*